Disgraced Theranos CEO Elizabeth Holmes' sentence hasn't changed, but like all prisoners who follow the rules, she can qualify for early release under the federal government's "good time" guidelines.
In another ruling issued late Tuesday, U.S. District Judge Edward Davila ordered Elizabeth Holmes to pay $452 million in restitution to the victims of her crimes.
The founder of the failed blood-testing startup Theranos will not begin her 11-year prison term on Thursday as expected due to an automatic delay triggered by her filing an appeal.
Holmes was sentenced to 11 years in prison for defrauding investors out of more than $100 million. Now, she has asked a judge to remain free on bail until her appeal is heard.
A jury found Elizabeth Holmes' former business and romantic partner guilty in July on all 12 felony counts of defrauding Theranos investors and the patients that used the company's faulty blood tests.
Raising hundreds of millions dollars sends a startup's valuation soaring. It can also make serious prison time all but inevitable for those in Holmes' situation.
Holmes was convicted on charges related to defrauding investors who poured hundreds of millions of dollars into her blood-testing company, believing it would revolutionize health care.
The fallen Silicon Valley star faces up to 15 years in prison for defrauding investors in her blood-testing company. A U.S. senator is among those who have written letters asking for mercy.
In a court filing, her attorneys assert that former Theranos lab director Adam Rosendorff now regrets the role he played in convicting Holmes of investor fraud and conspiracy.
A document obtained by NPR through a public records request shows that Holmes reported to local authorities that she was allegedly assaulted in a frat house while she was attending the school.
Theranos whistleblower Tyler Shultz reflects on Elizabeth Holmes' jury verdict. Now running his own biotech firm, he says he see how the pressure to exaggerate "could create an Elizabeth Holmes."
Holmes, who was once seen as one of the most promising leaders in Silicon Valley, could spend up to 20 years in prison for defrauding investors of the blood-testing company.
After hearing about the impasse, the judge instructed the jury to keep deliberating. Jurors have been debating Holmes' fate for seven days in a trial that has stretched on for four months.
A jury in Silicon Valley has been weighing the fate of Holmes, the former tech executive whose blood-testing startup Theranos shot her to fame. She now faces criminal fraud charges.
